Skip navigation

Nova UCD Banner
UCD Search

 
 
 

twitter logo

Linkedin

NovaUCD

The Innovation and Technology Transfer Centre

An Lárionad Nuála agus Aistrithe Teicneolaíochta

Key NovaUCD Results

Key achievements made by NovaUCD during 2009 include:

  • Seven new UCD spin-out companies incorporated
  • Eighty-five invention disclosures reported
  • Forty-seven patent applications filed across all areas of life sciences, engineering and information communication technology including
         - 25 priority patent applications
         - 17 PCT (Patent Co-operation Treaty) applications
         - 5 national/regional patent applications
  • Fifteen licence agreements concluded with a range of indigenous and international companies
  • Fifteen new ventures completed the NovaUCD 2009 Campus Company Development Programme
  • BiancaMed successfully raised €6 million in second round funding
  • UCD’s most successful licence to date, a BSE (Bovine Spongiform Encephalopathy) test, has now earned over €2 million in royalty income for UCD
  • Several NovaUCD companies, including Duolog Technologies, Celtic Catalysts, Lightwave Technologies and Visor attracted investment         
  • The NovaUCD 2009 Innovation Award presented to Nicola Mitchell, founder Life Scientific and BioScientific Diagnostics         
  • Twenty-five knowledge-intensive ventures occupying 90% of the incubation space located at NovaUCD at year end

 During 2009 NovaUCD continued its various initiatives to support researchers and entrepreneurs.

  • NovaUCD arranged and hosted well over 100 events to increase awareness of intellectual property and other commercial issues and to promote a culture of entrepreneurship and innovation among researchers, students and staff
  • Accredited PhD modules in innovation and knowledge transfer were delivered as part of UCD’s Graduate Studies’ Structured PhD Programme
  • Increasing levels of support were provided by NovaUCD and its network for innovators and entrepreneurs in bringing their ideas from the research laboratory through proof-of-principle and prototype development to successful commercialisation.

Summary Key NovaUCD 2009 Metrics 

  • 7 new UCD spin-out incorporated
  • 25 companies located at NovaUCD
  • 85 invention disclosures
  • 25 priority patent applications
  • 17 PCT patent applications
  • 5 national/regional patent applications
  • 15 licence agreements
  • 15 new ventures completed NovaUCD’s 2009 CCDP

 Summary Key NovaUCD 2005-2009 Metrics 

  • ChangingWorlds acquired for $60 million
  • Over €3 million generated from commercialisation of research
  • 50 start-ups availed of NovaUCD’s incubation facilities
  • 13 new UCD spin-outs incorporated
  • 247 invention disclosures
  • 88 priority patent applications
  • 53 licence agreements.

For further information contact:

Micéal Whelan
Communications
t: + 353 1 716 3712
e: miceal.whelan@ucd.ie